{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:52:02Z","timestamp":1759938722879,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"16-17","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.clinbiochem.2012.07.091","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T00:37:26Z","timestamp":1342744646000},"page":"1450-1454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The involvement of nitric oxide in the physiopathology of hepatoportal sclerosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Tugrul","family":"Purnak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yavuz","family":"Beyazit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Ibis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyfettin","family":"Koklu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cumali","family":"Efe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersan","family":"Ozaslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aydin","family":"Ciftci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilyas","family":"Tenlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinbiochem.2012.07.091_bb0005","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0016-5085(84)80106-7","article-title":"Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly","volume":"86","author":"Okuda","year":"1984","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.07.091_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2002-23207","article-title":"Idiopathic portal hypertension and its pathology","volume":"22","author":"Okudaira","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clinbiochem.2012.07.091_bb0015","series-title":"Oxford textbook of clinical hepatology","first-page":"661","article-title":"Intrahepatic portal hypertension","author":"Benhamou","year":"1999"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.07.091_bb0020","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.24422","article-title":"Idiopathic noncirrhotic portal hypertension","volume":"54","author":"Schouten","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinbiochem.2012.07.091_bb0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/13543776.2011.556619","article-title":"Novel nitric oxide synthase inhibitors: a patent review","volume":"21","author":"Joubert","year":"2011","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.07.091_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.510300148","article-title":"Nitric oxide in liver injury","volume":"30","author":"Clemens","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.07.091_bb0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2036.2010.04311.x","article-title":"Role of nitric oxide in the treatment of non-alcoholic fatty liver by omega-3 fatty acids","volume":"32","author":"Beyazit","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.07.091_bb0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/rheumatology\/37.3.246","article-title":"Nitric oxide and inflammatory joint diseases","volume":"37","author":"Stichtenoth","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"10","key":"10.1016\/j.clinbiochem.2012.07.091_bb0045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1872-034X.2009.00539.x","article-title":"Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease","volume":"39","author":"Yoneda","year":"2009","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.07.091_bb0050","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12072-007-9010-9","article-title":"Noncirrhotic portal fibrosis\/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment","volume":"1","author":"Sarin","year":"2007","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.07.091_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neures.2005.06.005","article-title":"Effects of acute ammonia toxicity on nitric oxide (NO), citrulline-NO cycle enzymes, arginase and related metabolites in different regions of rat brain","volume":"53","author":"Swamy","year":"2005","journal-title":"Neurosci Res"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.07.091_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1440-1746.2002.02596.x","article-title":"Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature","volume":"17","author":"Dhiman","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.07.091_bb0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0016-5085(78)90403-1","article-title":"Portal hypertension in vinyl chloride monomer workers. A hemodynamic study","volume":"75","author":"Blendis","year":"1978","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.07.091_bb0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0168-8278(91)90086-Q","article-title":"Arsenic and non-cirrhotic portal hypertension","volume":"13","author":"Guha Mazumdar","year":"1991","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinbiochem.2012.07.091_bb0075","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0016-5085(88)90255-7","article-title":"Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits","volume":"94","author":"Kono","year":"1988","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.07.091_bb0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1172\/JCI119121","article-title":"Bacterial infection induces nitric oxide synthase in human neutrophils","volume":"99","author":"Wheeler","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.07.091_bb0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00005373-199801000-00025","article-title":"The relationships among nitric oxide production, bacterial translocation, and intestinal injury after endotoxin challenge in vivo","volume":"44","author":"Mishima","year":"1998","journal-title":"J Trauma"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.07.091_bb0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/ard.56.5.330","article-title":"Increased serum NG-hydroxy-l-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity","volume":"56","author":"Wigand","year":"1997","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.07.091_bb0095","first-page":"1066","article-title":"Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus","volume":"24","author":"Rolla","year":"1997","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.07.091_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002960050055","article-title":"Nitric oxide synthesis is increased in patients with systemic lupus erythematosus","volume":"18","author":"Wanchu","year":"1998","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.07.091_bb0105","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/niox.2000.0309","article-title":"Increased nitric oxide production in patients with systemic sclerosis","volume":"4","author":"Sud","year":"2000","journal-title":"Nitric Oxide"},{"issue":"7","key":"10.1016\/j.clinbiochem.2012.07.091_bb0110","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/gut.2003.036806","article-title":"Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody","volume":"53","author":"Austin","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.07.091_bb0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.07.091_bb0120","first-page":"121","article-title":"Hepatoportal sclerosis associated with portal vein thrombosis in children: report of 3 cases","volume":"34","author":"Hessel","year":"1997","journal-title":"Arq Gastroenterol"},{"issue":"12","key":"10.1016\/j.clinbiochem.2012.07.091_bb0125","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s10620-006-9596-0","article-title":"Clinical features, serum interleukin-6, and interferon-gamma levels of 34 turkish patients with hepatoportal sclerosis","volume":"52","author":"Koksal","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.07.091_bb0130","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0272-6386(96)90515-6","article-title":"Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury","volume":"27","author":"Noris","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.clinbiochem.2012.07.091_bb0135","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1007\/s10620-011-1580-7","article-title":"Elevated levels of circulating angiotensin converting enzyme in patients with hepatoportal sclerosis","volume":"56","author":"Beyazit","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.07.091_bb0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hep.510300235","article-title":"Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension","volume":"30","author":"Kamath","year":"1999","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinbiochem.2012.07.091_bb0145","doi-asserted-by":"crossref","first-page":"R1288","DOI":"10.1152\/ajpregu.00397.2010","article-title":"The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives","volume":"300","author":"Bourque","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"8","key":"10.1016\/j.clinbiochem.2012.07.091_bb0150","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s10620-006-9146-9","article-title":"Significance of enhanced expression of nitric oxide syntheses in splenic sinus lining cells in altered portal hemodynamics of idiopathic portal hypertension","volume":"52","author":"Sato","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.07.091_bb0155","doi-asserted-by":"crossref","first-page":"G980","DOI":"10.1152\/ajpgi.00336.2005","article-title":"Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state","volume":"290","author":"Abraldes","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.clinbiochem.2012.07.091_bb0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1478-3231.2011.02579.x","article-title":"Endothelial dysfunction in the regulation of cirrhosis and portal hypertension","volume":"32","author":"Iwakiri","year":"2012","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.clinbiochem.2012.07.091_bb0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2005.02.022","article-title":"Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats","volume":"43","author":"Fernandez","year":"2005","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.clinbiochem.2012.07.091_bb0170","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.gastro.2003.07.014","article-title":"Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats","volume":"125","author":"Tsai","year":"2003","journal-title":"Gastroenterology"},{"issue":"6 Pt 1","key":"10.1016\/j.clinbiochem.2012.07.091_bb0175","first-page":"G996","article-title":"In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade","volume":"262","author":"Sieber","year":"1992","journal-title":"Am J Physiol"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012004341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012004341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:41:05Z","timestamp":1757864465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012004341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":35,"journal-issue":{"issue":"16-17","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0009912012004341"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.07.091","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The involvement of nitric oxide in the physiopathology of hepatoportal sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.07.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}